SpineGuard Q3 2026 revenue falls 14% to EUR 662,000

PUBT · 1d ago
SpineGuard Q3 2026 revenue falls 14% to EUR 662,000
  • SpineGuard posted Q3 2026 revenue of EUR 662,000, down 14% year on year, reflecting a shift to a US distribution model.
  • Units sold rose 22% to 1,398, despite the revenue decline; Q3 revenue increased 5% versus Q2.
  • US Q3 revenue fell to USD 334,000 from USD 548,000; unit volumes increased 7% on steadier Omnia Medical orders.
  • Revenue outside the US rose 25% to EUR 377,000 from EUR 302,000, driven by Europe, Asia, the Middle East.
  • Cash position totaled EUR 882,000 at Sept. 30, 2026; target remains operating breakeven in Q4 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SpineGuard SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20261008795945) on October 08, 2026, and is solely responsible for the information contained therein.